For decades, many Americans with hepatitis C have struggled to get tested or died waiting for a cure that remained inaccessibly expensive within the nation’s fractured health care system. President ...

Hepatitis C is the leading blood borne infection, and the number one cause of liver disease in the United States. The Center for Disease Control estimates that 2.7 million people in the US are ...

A Stanford study shows that jail-based hepatitis C programs could cut new infections by nearly half among people who inject ...

Epclusa (sofosbuvir/velpatasvir) is a brand-name prescription medication. It’s approved by the Food and Drug Administration (FDA) to treat hepatitis C, which is an ...

For a decade now, the world has had highly effective medications for hepatitis C infections. In the United States, they’ve mostly been sitting on the shelf, according to a new study. These drugs, ...

Ashwin Dhanda does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...

Despite an arsenal of drugs, many Americans are still unaware of their infections until it’s too late. A Biden initiative languishes without Congressional approval. By Ted Alcorn In the 10 years since ...